Correvio Pharma Corp. Long-Term Debt, Maturity, Year Four
Correvio Pharma Corp. had Long-Term Debt, Maturity, Year Four of $8.70 million as of 2018-12-31, per its 40-F filed 2019-03-13.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2019-03-13
- 2018-12-31: Long-Term Debt, Maturity, Year Four $8.70M.
- 2017-12-31: Long-Term Debt, Maturity, Year Four $20.39M.
- 2016-12-31: Long-Term Debt, Maturity, Year Four $10.00M.
- 2014-12-31: Long-Term Debt, Maturity, Year Four $2.06M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2018-12-31 | $8.70M 40-F · filed 2019-03-13 |
| 2017-12-31 | $20.39M 20-F · filed 2018-04-30 |
| 2016-12-31 | $10.00M 40-F · filed 2017-03-29 |
| 2014-12-31 | $2.06M 40-F · filed 2015-03-27 |